We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Spot Urine Sample Evaluated for Renal Potassium Loss

By LabMedica International staff writers
Posted on 02 Dec 2020
Hypokalemia is characterized by low serum potassium concentrations. More...
Severe hypokalemia can be life threatening, and immediate potassium replacement is often required to prevent sudden cardiac arrest.

Initial identification of hypokalemia etiology is based on an estimate of urine potassium excretion during a 24-hr urine collection in the absence of potassium supplementation, but the utility of this approach in the emergency department is limited.

Endocrinologists at The Affiliated Hospital of Southwest Medical University (Luzhou, China) divided patients with hypokalemia were into two groups: 67 patients with hypokalemia caused by renal potassium loss and 63 patients with hypokalemia caused by extrarenal potassium loss. Arterial blood gases were measured with an ABL800 blood gas analyzer (Radiometer, Copenhagen, Denmark).

Urine potassium concentration (UK), urine creatinine concentration (UCr), urine potassium-creatinine ratio (UK/UCr), fractional excretion of potassium (FEK), transtubular potassium concentration gradient (TTKG), and 24-h urine potassium excretion (24 hUK-calculated) were derived from spot urine samples collected on admission, and were determined using automated methods on a 7170A automatic biochemistry analyzer (Hitachi Healthcare, Tokyo, Japan).

The scientists reported that patients with hypokalemia caused by renal potassium loss had significantly higher UK, UK/UCr, FEK, TTKG and 24 hUK-calculated compared to patients with hypokalemia caused by extrarenal potassium loss. FEK predicted renal potassium loss in hypokalemia with high accuracy at a cut-off of 9.29% (sensitivity, 80.6%; specificity, 85.7%). Patients with primary aldosteronism had significantly higher UK and TTKG compared to patients without primary aldosteronism. There were no significant differences in UK/UCr, FEK or 24 hUK-calculated between patients with primary aldosteronism and not primary aldosteronism. On the spot urine test, FEK showed the highest correlation with 24 hUK-actual during low or high dose potassium chloride infusion.

The authors concluded that prompt treatment with potassium chloride is required for patients with hypokalemia; 24 hUK-actual is not a suitable marker for predicting renal potassium loss in medical practice. Findings from this study suggest that a spot urine sample collected before potassium chloride therapy has utility for differentiating between renal and extrarenal potassium loss in hypokalemia. FEK from a spot urine sample represents a convenient and reliable parameter to predict renal potassium loss in patients with hypokalemia. The study will be published in the December, 2020 issue of the journal Clinica Chimica Acta.

Related Links:
The Affiliated Hospital of Southwest Medical University
Radiometer
Hitachi Healthcare



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.